GREENVILLE, SC (FOX Carolina) – Prisma Health said Wednesday one of their hospitals is participating in an international clinical study of the drug Remdesivir as a potential treatment for moderate and severe COVID-19 patients.

Prisma said Remdesivir is an antiviral medication developed by the U.S. biopharmaceutical company Gilead Sciences.

“Following